COVID-19 Therapies

06/01/2022

Interim Clinical Commissioning Policy - IL-6 inhibitors - 14 Sep 2021.pdf

06/01/2022

COVID 19 Therapeutic alert - Withdrawal of budesonide - 14 Dec 2021.pdf

06/01/2022

Pharmaceutical Public Link - Withdrawal of Budesonide - 14 Dec 2021.pdf

17/05/2021

COVID-19 Therapeutic Alert - Convalescent Plasma - 17 March 2021.pdf

17/05/2021

Public Health Link - Convalescent Plasma - 17 March 2021.pdf

17/05/2021

COVID-19 Therapeutic Alert - Budesonide - 12 April 2021.pdf

17/05/2021

Pharmaceutical Public Link - Budesonide - 13 April 2021.pdf

17/05/2021

Interim Position Statement - Inhaled Budesonide - 12 April 2021.pdf

17/05/2021

Public health Link - Astra Zeneca vaccine - 16 April 2021.pdf

17/05/2021

Public health Link - Thrombosis with thrombocytopenia following AZ vaccine - 07 May 2021.pdf

22/02/2021

Interim Clinical Commissioning Policy - tocilizumab - 17 Feb 2021.pdf

22/02/2021

Interim Clinical Commissioning Policy - sarilumab - 17 Feb 2021.pdf

22/02/2021

COVID-19 Therapeutic Alert - tocilizumab or sarilumab - 17 Feb 2021.pdf

22/02/2021

PublicHealthLink - IL-6 inhibitors - 19 Feb 2021.pdf

15/02/2021

COVID-19 Therapeutic Alert - 12 Feb 2021- Colchicine.pdf

15/02/2021

Public Health Link - 12 Feb 2021 - Colchicine.pdf

01/02/2021

Sarilumab_Interim_Policy - 4 February 2021.pdf

01/02/2021

Tocilizumab_Interim_Policy - 4 February 2021.pdf

01/02/2021

Public Health Link - 1 February 2021.pdf

01/02/2021

C-19 Therapeutic Alert - IL-6 inhibtors - Feb 01.pdf